All Stories

  1. Spatial-temporal and phylogenetic analyses of epidemiologic data to help understand the modes of transmission of endemic typhoid fever in Samoa

    Article • PLoS Neglected Tropical Diseases, October 2022, PLOS

    Dr David A Rasko

  2. Comparative genomic analysis and molecular examination of the diversity of enterotoxigenic Escherichia coli isolates from Chile

    Article • PLoS Neglected Tropical Diseases, November 2019, PLOS

    Professor James Michael Fleckenstein, Dr David A Rasko

  3. Genetic changes associated with the temporal shift in invasive non-typhoidal Salmonella serovars in Bamako Mali

    Article • PLoS Neglected Tropical Diseases, June 2019, PLOS

    Dr David A Rasko

  4. Cumulative acquisition of pathogenicity islands has shaped virulence potential and contributed to the emergence of LEE-negative Shiga toxin-producing Escherichia coli strains

    Article • Emerging Microbes & Infections, January 2019, Taylor & Francis

    Dr David A Rasko, Mr Flemming Scheutz, Dr Roberto M Vidal

  5. Temporal Variability of Escherichia coli Diversity in the Gastrointestinal Tracts of Tanzanian Children with and without Exposure to Antibiotics

    Article • mSphere, November 2018, ASM Journals

    Dr David A Rasko

  6. A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge

    Article • mSphere, August 2018, ASM Journals

    Dr David A Rasko, Marcela Pasetti

  7. Responses of the Human GutEscherichia coliPopulation to Pathogen and Antibiotic Disturbances

    Article • mSystems, July 2018, ASM Journals

    Dr David A Rasko

  8. Draft Genome Sequences of bla KPC -Containing Enterobacter aerogenes , Citrobacter freundii , and ...

    Article • Genome Announcements, February 2018, ASM Journals

    Dr David A Rasko

  9. Characterization of a Large Antibiotic Resistance Plasmid Found in Enteropathogenic Escherichia coli Strain B171 and Its Relatedness to Plasmids of Diverse E. coli and Shigella Strains

    Article • Antimicrobial Agents and Chemotherapy, July 2017, ASM Journals

    Dr David A Rasko

  10. Use of Comparative Genomics To Characterize the Diversity of Acinetobacter baumannii Surveillance Isolates in a Health Care Institution

    Article • Antimicrobial Agents and Chemotherapy, July 2016, ASM Journals

    Dr David A Rasko

  11. Investigating the Relatedness of Enteroinvasive Escherichia coli to Other E. coli and Shigella Isolates by Using Comparative Genomics

    Article • Infection and Immunity, June 2016, ASM Journals

    Dr David A Rasko

  12. Comparative Genomics Provides Insight into the Diversity of the Attaching and Effacing Escherichia coli Virulence Plasmids

    Article • Infection and Immunity, August 2015, ASM Journals

    Dr David A Rasko

  13. Examination of the Enterotoxigenic Escherichia coli Population Structure during Human Infection

    Article • mBio, June 2015, ASM Journals

    Dr David A Rasko, Professor James Michael Fleckenstein

  14. Conservation and Immunogenicity of Novel Antigens in Diverse Isolates of Enterotoxigenic Escherichia coli

    Article • PLoS Neglected Tropical Diseases, January 2015, PLOS

    Dr David A Rasko, Professor James Michael Fleckenstein

  15. Blocking Yersiniabactin Import Attenuates Extraintestinal Pathogenic Escherichia coli in Cystitis and Pyelonephritis and Represents a Novel Target To Prevent Urinary Tract Infection

    Article • Infection and Immunity, January 2015, ASM Journals

    Dr David A Rasko, Dr Harry L. T. Hmobley

  16. Defining the Phylogenomics of Shigella Species: a Pathway to Diagnostics

    Article • Journal of Clinical Microbiology, January 2015, ASM Journals

    Dr David A Rasko

  17. Host-specific induction of Escherichia coli fitness genes during human urinary tract infection

    Article • Proceedings of the National Academy of Sciences, December 2014, Proceedings of the National Academy of Sciences

    Dr David A Rasko

  18. QseC Inhibitors as an Antivirulence Approach for Gram-Negative Pathogens

    Article • mBio, November 2014, ASM Journals

    Dr David A Rasko

  19. Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution

    Article • Nature Genetics, November 2014, Springer Science + Business Media

    Dr David A Rasko

  20. EHEC Genomics: Past, Present, and Future

    Article • Microbiology Spectrum, August 2014, ASM Journals

    Dr David A Rasko

  21. Draft Genome Sequences of Nine Enteropathogenic Escherichia coli Strains from Kenya

    Article • Genome Announcements, June 2014, ASM Journals

    Dr David A Rasko

  22. Genomic and Virulence Heterogeneity of Enteroaggregative Escherichia coli

    Article • April 2014, ASM Journals

    Dr David A Rasko

  23. The large-scale blast score ratio (LS-BSR) pipeline: a method to rapidly compare genetic content between bacterial genomes

    Article • PeerJ, April 2014, PeerJ

    Dr David A Rasko

  24. High Frequency, Spontaneous motA Mutations in Campylobacter jejuni Strain 81-176

    Article • PLoS ONE, February 2014, PLOS

    Dr David A Rasko

  25. H-NST Induces LEE Expression and the Formation of Attaching and Effacing Lesions in Enterohemorrhagic Escherichia coli

    Article • PLoS ONE, January 2014, PLOS

    Dr David A Rasko

  26. Characterization of Klebsiella sp. Strain 10982, a Colonizer of Humans That Contains Novel Antibiotic Resistance Alleles and Exhibits Genetic Similarities to Plant and Clinical Klebsiella Isolates

    Article • Antimicrobial Agents and Chemotherapy, January 2014, ASM Journals

    Dr David A Rasko

  27. A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis‐specific lipid A

    Article • Molecular Microbiology, November 2013, Wiley

    Dr David A Rasko, Dr Robert Ernst

  28. Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions

    Article • Nature Reviews Genetics, November 2013, Springer Science + Business Media

    Dr David A Rasko

  29. EnterotoxigenicEscherichia coli

    Article • Gut Microbes, September 2013, Taylor & Francis

    Dr David A Rasko, Professor James Michael Fleckenstein

  30. Draft Genome Sequences of Three O157 Enteropathogenic Escherichia coli Isolates

    Article • Genome Announcements, July 2013, ASM Journals

    Dr David A Rasko

  31. Draft genome sequences of five recent human uropathogenic Escherichia coli isolates

    Article • Pathogens and Disease, July 2013, Oxford University Press (OUP)

    Dr David A Rasko

  32. Characterization of Intracellular Growth RegulatoricgRby Utilizing Transcriptomics To Identify Mediators of Pathogenesis in Shigella flexneri

    Article • Infection and Immunity, June 2013, ASM Journals

    Dr David A Rasko

  33. Differential Response of the Cynomolgus Macaque Gut Microbiota to Shigella Infection

    Article • PLoS ONE, June 2013, PLOS

    Dr David A Rasko

  34. Impact of Oral Typhoid Vaccination on the Human Gut Microbiota and Correlations with S. Typhi-Specific Immunological Responses

    Article • PLoS ONE, April 2013, PLOS

    Dr David A Rasko

  35. 1151 TRANSCRIPTOME OF UROPATHOGENIC ESCHERICHIA COLI DURING HUMAN URINARY TRACT INFECTIONS

    Article • The Journal of Urology, April 2013, Wolters Kluwer Health

    Dr David A Rasko

  36. The Human Microbiome: From Symbiosis to Pathogenesis

    Article • Annual Review of Medicine, January 2013, Annual Reviews

    Dr David A Rasko

  37. Comparative genomics of pathogenic Escherichia coli

    Article • January 2013, Elsevier

    Dr David A Rasko

  38. Clostridium difficile healthcare-associated epidemics

    Article • Nature Genetics, December 2012, Springer Science + Business Media

    Dr David A Rasko

  39. Hybrid error correction and de novo assembly of single-molecule sequencing reads

    Article • Nature Biotechnology, July 2012, Springer Science + Business Media

    Dr David A Rasko

  40. The Shigella OspE1 and OspE2 Adhesins

    Article • Molecular Microbiology, May 2012, Wiley

    Dr David A Rasko, Dr. Christina S. Faherty

  41. Comparative Genomics and stx Phage Characterization of LEE-Negative Shiga Toxin-Producing Escherichia coli

    Article • Frontiers in Cellular and Infection Microbiology, January 2012, Frontiers

    Dr David A Rasko

  42. Investigating the genome diversity of B. cereus and evolutionary aspects of B. anthracis emergence

    Article • Genomics, July 2011, Elsevier

    Dr David A Rasko

  43. Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity

    Article • BMC Genomics, June 2011, Springer Science + Business Media

    Dr David A Rasko

  44. Escherichia coli Global Gene Expression in Urine from Women with Urinary Tract Infection

    Article • PLoS Pathogens, November 2010, PLOS

    Dr David A Rasko

  45. Bacillus anthracisPlasmids: Species Definition or Niche Adaptation?

    Article • November 2010, Wiley

    Dr David A Rasko

  46. Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains

    Article • American Journal of Infection Control, November 2010, Elsevier

    Dr David A Rasko

  47. The LysR‐type regulator QseA regulates both characterized and putative virulence genes in enterohaemorrhagic Escherichia coli O157:H7

    Article • Molecular Microbiology, May 2010, Wiley

    Dr David A Rasko

  48. Molecular mechanisms of enterotoxigenic Escherichia coli infection

    Article • Microbes and Infection, February 2010, Elsevier

    Dr David A Rasko, Professor James Michael Fleckenstein

  49. Complete Genome Sequence and Comparative Metabolic Profiling of the Prototypical Enteroaggregative Escherichia coli Strain 042

    Article • PLoS ONE, January 2010, PLOS

    Dr David A Rasko, Professor Julian Parkhill

  50. Anti-virulence strategies to combat bacteria-mediated disease

    Article • Nature Reviews Drug Discovery, January 2010, Springer Science + Business Media

    Dr David A Rasko

  51. Outbreak Caused by cad -Negative Shiga Toxin–Producing Escherichia coli O111, Oklahoma

    Article • Foodborne Pathogens and Disease, January 2010, Mary Ann Liebert Inc

    Dr David A Rasko

  52. The Role of Genomics in the Identification, Prediction, and Prevention of Biological Threats

    Article • PLoS Biology, October 2009, PLOS

    Dr David A Rasko

  53. The QseC Adrenergic Signaling Cascade in Enterohemorrhagic E. coli (EHEC)

    Article • PLoS Pathogens, August 2009, PLOS

    Dr David A Rasko

  54. Role of the K2 Capsule in Escherichia coli Urinary Tract Infection and Serum Resistance

    Article • The Journal of Infectious Diseases, June 2009, Oxford University Press (OUP)

    Dr David A Rasko

  55. Novel Approaches to Bacterial Infection Therapy by Interfering with Cell‐to‐Cell Signaling

    Article • Current Protocols in Microbiology, February 2009, Wiley

    Dr David A Rasko

  56. Development of novel plasmid vectors and a promoter trap system in Francisella tularensis compatible with the pFLN10 based plasmids

    Article • Plasmid, September 2007, Elsevier

    Dr David A Rasko

  57. The Complete Genome Sequence of Yersinia pseudotuberculosis IP31758, the Causative Agent of Far East Scarlet-Like Fever

    Article • PLoS Genetics, August 2007, PLOS

    Dr David A Rasko

  58. Multiple Antimicrobial Resistance in Plague: An Emerging Public Health Risk

    Article • PLoS ONE, March 2007, PLOS

    Dr David A Rasko

  59. Genomics of the Bacillus cereus group of organisms

    Article • FEMS Microbiology Reviews, April 2005, Oxford University Press (OUP)

    Dr David A Rasko

  60. Major Structural Differences and Novel Potential Virulence Mechanisms from the Genomes of Multiple Campylobacter Species

    Article • PLoS Biology, January 2005, PLOS

    Dr David A Rasko

  61. Genome Sequence of Y. pseudotuberculosis IP31758, the Causative Agent of Far East Scarlet Like Fever: Linking Genomic Plasticity to Pathogenicity

    Article • PLoS Genetics, January 2005, PLOS

    Dr David A Rasko

  62. Bugs N the 'hood

    Article • Trends in Microbiology, April 2004, Elsevier

    Dr David A Rasko

  63. Lewis antigens in Helicobacter pylori: biosynthesis and phase variation

    Article • Molecular Microbiology, January 2002, Wiley

    Dr David A Rasko

  64. Identification of DNA Sequences from a Second Pathogenicity Island of Uropathogenic Escherichia coli CFT073: Probes Specific for Uropathogenic Populations

    Article • The Journal of Infectious Diseases, October 2001, Oxford University Press (OUP)

    Dr David A Rasko

  65. Lewis Antigen Expression by Helicobacter pylori

    Article • The Journal of Infectious Diseases, August 2001, Oxford University Press (OUP)

    Dr David A Rasko

  66. Helicobacter pylorifrom asymptomatic hosts expressing heptoglycan but lacking Lewis O-chains: Lewis blood-group O-chains may play a role inHelicobacter pyloriinduced pathology

    Article • Biochemistry and Cell Biology, August 2001, Canadian Science Publishing

    Dr David A Rasko

  67. <i>Helicobacter pylori</i> from asymptomatic hosts expressing heptoglycan but lacking Lewis O-chains: Lewis blood-group O-chains may play a role in <i>Helicobacter pylori</i> induced pathology

    Article • Biochemistry and Cell Biology, January 2001, Canadian Science Publishing

    Dr David A Rasko

  68. Synthesis of mono‐ and di‐fucosylated type I Lewis blood group antigens by Helicobacter pylori

    Article • European Journal of Biochemistry, October 2000, Wiley

    Dr David A Rasko

  69. Lewis antigen phenotype is altered in Helicobacter pylori isolated from asymptomatic subjects

    Article • Gastroenterology, April 2000, Elsevier

    Dr David A Rasko

  70. Lewis Antigen Expression and Stability in Helicobacter pylori Isolated from Serial Gastric Biopsies

    Article • The Journal of Infectious Diseases, March 2000, Oxford University Press (OUP)

    Dr David A Rasko

  71. Molecular genetic basis for the variable expression of Lewis Y antigen in Helicobacter pylori : analysis of the α(1,2) fucosyltransferase gene

    Article • Molecular Microbiology, February 1999, Wiley

    Dr David A Rasko

  72. Glucosylated N-acetyllactosamine O-antigen chain in the lipopolysaccharide from Helicobacter Pylori strain UA861

    Article • Carbohydrate Polymers, December 1997, Elsevier

    Dr David A Rasko